Trial intelligence / Profile preview

Effect of Neuromuscular Blocking Agent Use on Video Laryngeal Mask Airway Insertion

NCT07894029Phase 4Not yet recruiting

Sponsor
Hacettepe University
Start
Feb 2027
Primary completion
Feb 2028
Countries
1
01

Overview

A Phase 4 trial of rocuronium, sponsored by Hacettepe University. Planned start Feb 2027; status: not yet recruiting.

02

Drugs

rocuronium

Beyond the preview

Go deeper on NCT07894029.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07894029.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call